Top Growth Trends in the Irritable Bowel Syndrome (IBS) Treatment Market: Insights into Market Size and Opportunities for 2025-2034
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
What Are the Primary Drivers Supporting the Market Growth of theIrritable Bowel Syndrome (IBS) Treatment Market?
The increase in the number of cases related to irritable bowel syndrome (IBS) is predicted to stimulate the expansion of the market for its treatment. IBS is a long-term disorder of the gastrointestinal system that predominantly affects the large intestine or colon. The escalation in the incidence of IBS is largely attributed to unhealthy lifestyles, poor dietary practices, pollution exposure, and heightened stress levels. Treatment for IBS aims to mitigate the intensity and regularity of its symptoms, enhancing the patient’s quality of life and empowering them to better manage their ailment. For example, the International Foundation for Gastrointestinal Disorders (IFFGD), an American non-profit educational and research entity, approximates that around 5-10% of the global population will be suffering from IBS in 2023, with about 25 to 45 million individuals in the United States alone. Hence, this surge in IBS cases is fueling the progression of the IBS treatment market.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11978&type=smp
#What is the Anticipated CAGR of theIrritable Bowel Syndrome (IBS) Treatment Market, and What Factors Will Drive It?
Recent years have seen a swift expansion in the market size for treatment of irritable bowel syndrome (IBS), expected to increase from $2.79 billion in 2024 to $3.07 billion in 2025, boasting a compound annual growth rate (CAGR) of 10.2%. The past growth rate owes much to the rising prevalence of IBS, heightening patient awareness, stress and lifestyle factors, the role of patient advocacy and support groups, as well as healthcare reimbursement policies.
Anticipated to experience swift expansion in the coming years, the market size for irritable bowel syndrome (IBS) treatment is predicted to reach $4.93 billion in 2029, with a compound annual growth rate (CAGR) of 12.5%. The forecasted period’s growth is accredited to aspects like patient-oriented healthcare systems, the application of microbial therapies, blockchain incorporation in healthcare, results reported by patients (pros), swift regulatory programs, and interoperability of health data. Some major trends noted during this forecast period encompass the broad integration of digital health solutions, technological advancements in diagnostics, elevated investments in research and development, collaborations, and partnerships, and the rise of non-drug therapies.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11978
What Are the Latest Innovations Influencing theIrritable Bowel Syndrome (IBS) Treatment Market?
The development of innovative products is being recognized as a leading trend in the irritable bowel syndrome (IBS) market. Main players in the irritable bowel syndrome (IBS) market are focusing on crafting advanced, unique products to reinforce their market standing. For example, in April 2022, Ardelyx, a biotech company from the US, introduced IBSRELA, a pioneering treatment for IBS-C in adults. It is the sole NHE3 inhibitor available for treating adult IBS with constipation (IBS-C). IBSRELA, the first Ardelyx medication to secure FDA approval, is the initial novel mechanism therapy for IBS-C (irritable bowel syndrome-constipation) produced in nearly a decade, providing a significant new alternative for managing constipation, bloating, and stomach discomfort, which are symptoms of this debilitating condition.
Who Are the Major Industry Players Accelerating Growth in theIrritable Bowel Syndrome (IBS) Treatment Market?
Major companies operating in the irritable bowel syndrome (IBS) treatment market include Pfizer Inc., Johnson & Johnson Services Inc., AbbVie Inc., Novartis AG, AstraZeneca plc, Abbott Laboratories, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Astellas Pharma Inc., Biogen Inc., Bausch Health Companies Inc., Ironwood Pharmaceuticals Inc., Sebela Pharmaceuticals Inc., Prometheus Laboratories Inc., RedHill Biopharma Ltd., Ardelyx Inc., Cosmo Technologies Ltd., Renexxion Ireland Ltd., 4D Pharma plc, Biora Therapeutics Inc.
Order Your Report Now For A Swift Delivery:
Which Primary Segments of the Irritable Bowel Syndrome (IBS) Treatment Market Are Driving Growth and Industry Transformations?
The irritable bowel syndrome (IBS) treatment market covered in this report is segmented –
1) By Drug Type: Lubiprostone, Linaclotide, Eluxadoline, Rifaximin, Alosetron, Other Drugs
2) By Indication: IBS With Constipation, IBS With Diarrhea, IBS With Alternating Constipation And Diarrhea
3) By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies
4) By End-Users: Hospitals, Clinics, Homecare Settings
Subsegments:
1) By Lubiprostone: Chronic Idiopathic Constipation Treatment, Irritable Bowel Syndrome with Constipation (IBS-C) Treatment
2) By Linaclotide: IBS-C Treatment, Chronic Idiopathic Constipation Treatment
3) By Eluxadoline: IBS with Diarrhea (IBS-D) Treatment
4) By Rifaximin: IBS-D Treatment, Small Intestinal Bacterial Overgrowth (SIBO) Treatment
5) By Alosetron: Severe IBS-D Treatment for Women
6) By Other Drugs: Prucalopride, Tenapanor, Plecanatide
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=11978&type=smp
Which Regions Are Key Players in the Growth of the #What Are the Primary Drivers Supporting the Market Growth of theIrritable Bowel Syndrome (IBS) Treatment Market?# Market?
North America was the largest region in the irritable bowel syndrome (IBS) treatment market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the irritable bowel syndrome (IBS) treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Reports Similar to the Gobal Irritable Bowel Syndrome (IBS) Treatment Maret 2025, By The Business Research Company:
Aerospace Interior Adhesive Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/aerospace-interior-adhesive-global-market-report
Aerospace Plastics Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/aerospace-plastics-global-market-report
Aerospace Coatings Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/aerospace-coatings-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
